Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$13.69 USD
-0.31 (-2.21%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $13.69 0.00 (0.00%) 7:50 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Arcus Biosciences, Inc. [RCUS]
Reports for Purchase
Showing records 1 - 20 ( 124 total )
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Going With the Gut: EDGE-Gastric and ARC-9 at ASCO
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
1Q:24 Financials; Late-Stage Dev Continuing for HIF-2a, TIGIT, Adenosine
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Q4/FY23 Financials; Cas Initial Topline Efficacy; STAR-131 in Periop NSCLC
Provider: Wedbush Securities Inc.
Analyst: ERT V
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Quemli High mOS in mPDAC; Tira in EC Supports Dom in GI
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
RCUS, EXEL to Initiate Ph1b/2 STELLAR-009 of Zanza+AB521 in Solid Tumors, ccRCC
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- SKYSCRAPER, Episode IV: A New Hope
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D